Thus, EVs carrying IRF5 may activate the local microenvironment to be more “anti-tumor” whereas the lack of IRF5 creates a “pro-tumor” microenvironment with increased MDSCs, TAMs, and inhibition of activated T cells. Here, IRF5 is linked to neoplasm.